Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5470) 5470
Publication (763) 763
Book Review (53) 53
Book Chapter (29) 29
Book / eBook (25) 25
Magazine Article (11) 11
Dissertation (8) 8
Conference Proceeding (6) 6
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4977) 4977
female (3622) 3622
papillomaviridae - immunology (2499) 2499
adult (1994) 1994
index medicus (1900) 1900
papillomaviridae - genetics (1844) 1844
human papillomavirus (1614) 1614
middle aged (1430) 1430
papillomaviridae - isolation & purification (1421) 1421
male (1366) 1366
papillomavirus infections (1327) 1327
papillomavirus infections - virology (1304) 1304
animals (1208) 1208
cancer (1178) 1178
immunology (1165) 1165
uterine cervical neoplasms - virology (1102) 1102
cervical cancer (1082) 1082
oncology (936) 936
adolescent (911) 911
virology (890) 890
papillomavirus infections - immunology (860) 860
papillomavirus infections - prevention & control (843) 843
aged (838) 838
infection (814) 814
infectious diseases (807) 807
papillomavirus infections - epidemiology (803) 803
prevalence (782) 782
women (748) 748
hpv (734) 734
risk factors (711) 711
papillomaviridae - classification (697) 697
papillomavirus infections - complications (695) 695
dna (640) 640
papillomaviridae (634) 634
dna, viral - analysis (602) 602
vaccination (585) 585
tumor virus infections - immunology (566) 566
mice (558) 558
papillomaviruses (550) 550
health aspects (549) 549
microbiology (544) 544
uterine cervical neoplasms - prevention & control (540) 540
uterine cervical neoplasms - immunology (526) 526
polymerase chain reaction (525) 525
viruses (521) 521
cervical-cancer (520) 520
oncogene proteins, viral - immunology (517) 517
young adult (511) 511
infections (509) 509
vaccines (482) 482
research article (463) 463
papillomaviridae - pathogenicity (448) 448
research (440) 440
papillomavirus infections - diagnosis (439) 439
genotype (438) 438
cervical intraepithelial neoplasia (418) 418
immunization (418) 418
virus diseases (415) 415
virus-like particles (411) 411
cervical intraepithelial neoplasia - virology (404) 404
uterine cervical neoplasms - pathology (400) 400
risk (391) 391
lesions (390) 390
dna, viral - genetics (389) 389
molecular sequence data (387) 387
oncogene proteins, viral - genetics (377) 377
antibodies, viral - blood (371) 371
papillomavirus infections - pathology (361) 361
carcinoma, squamous cell - virology (358) 358
papillomaviridae - physiology (354) 354
pathology (352) 352
intraepithelial neoplasia (350) 350
analysis (345) 345
medicine, research & experimental (341) 341
expression (340) 340
papillomavirus vaccines - immunology (328) 328
medicine (323) 323
child (314) 314
epidemiology (309) 309
uterine cervical neoplasms - epidemiology (306) 306
papillomavirus vaccines (301) 301
papillomavirus e7 proteins (300) 300
proteins (300) 300
antibodies (296) 296
young-women (291) 291
antigens, viral - analysis (288) 288
multidisciplinary sciences (285) 285
prevention (282) 282
neoplasia (274) 274
article (272) 272
aged, 80 and over (268) 268
immunohistochemistry (267) 267
squamous-cell carcinoma (264) 264
base sequence (262) 262
amino acid sequence (254) 254
tumor virus infections - complications (252) 252
cervix (251) 251
natural-history (250) 250
cervix uteri - virology (249) 249
deoxyribonucleic acid--dna (248) 248
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5246) 5246
French (72) 72
Chinese (49) 49
German (40) 40
Japanese (28) 28
Spanish (19) 19
Italian (16) 16
Russian (14) 14
Polish (10) 10
Dutch (6) 6
Czech (4) 4
Finnish (3) 3
Swedish (3) 3
Danish (2) 2
Serbian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
by Zwaveling, Sander and Mota, Sandra C. Ferreira and Nouta, Jan and Johnson, Mark and Lipford, Grayson B and Offringa, Rienk and van der Burg, Sjoerd H and Melief, Cornelis J. M
The Journal of Immunology, ISSN 0022-1767, 07/2002, Volume 169, Issue 1, pp. 350 - 358
Peptide-based vaccines aimed at the induction of effective T cell responses against established cancers have so far only met with limited clinical success and... 
CANCER-PATIENTS | DENDRITIC CELLS | CTL EPITOPES | IN-VIVO | CERVICAL LESIONS | MONOPHOSPHORYL LIPID-A | GENITAL WARTS | IMMUNOLOGY | NATURAL-HISTORY | YOUNG-WOMEN | CYTOTOXIC T-LYMPHOCYTES | Oncogene Proteins, Viral - administration & dosage | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Dendritic Cells - immunology | Humans | Molecular Sequence Data | Papillomavirus E7 Proteins | Th1 Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Papillomaviridae - immunology | CD40 Antigens - metabolism | CD40 Ligand - metabolism | Immunization, Secondary | Injections, Subcutaneous | Peptide Fragments - immunology | Tumor Virus Infections - immunology | Papillomavirus Infections - immunology | Epitopes, T-Lymphocyte - immunology | Tumor Cells, Cultured | Dendritic Cells - metabolism | Disease Models, Animal | Amino Acid Sequence | Oligodeoxyribonucleotides - immunology | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Cells, Cultured | Vaccines, Subunit - immunology | Oncogene Proteins, Viral - biosynthesis | Tumor Virus Infections - prevention & control | Mice, Knockout | Viral Vaccines - administration & dosage | Animals | Histocompatibility Antigens Class II - immunology | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Mice | Oncogene Proteins, Viral - immunology | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | Cell Line, Transformed
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16
by Gunn, George R and Zubair, Abba and Peters, Christian and Pan, Zhen-Kun and Wu, Tzyy-Choou and Paterson, Yvonne
The Journal of Immunology, ISSN 0022-1767, 12/2001, Volume 167, Issue 11, pp. 6471 - 6479
Two recombinant Listeria monocytogenes (rLm) strains were produced that secrete the human papilloma virus-16 (HPV-16) E7 protein expressed in HPV-16-associated... 
IN-VITRO | EPITOPE | PROTEIN | IMMUNOTHERAPY | NEOPLASIA | IMMUNOLOGICAL SELF-TOLERANCE | CERVICAL-CANCER | TYPE-16 | MICE | IMMUNOLOGY | ANTIGEN | Spleen - immunology | Bacterial Vaccines - genetics | Humans | Papillomavirus E7 Proteins | Listeria monocytogenes - immunology | Vaccines, Synthetic - immunology | Papillomaviridae - genetics | Cancer Vaccines - genetics | Tumor Cells, Cultured - pathology | Heat-Shock Proteins - genetics | Lymphocyte Activation - genetics | Papillomaviridae - immunology | Tumor Cells, Cultured - virology | Bacterial Toxins | Listeria monocytogenes - metabolism | Oncogene Proteins, Viral - genetics | Epitopes, T-Lymphocyte - immunology | Cell Line, Transformed - immunology | Oncogene Proteins, Viral - metabolism | Papillomavirus Vaccines | Cell Line, Transformed - virology | T-Lymphocytes, Cytotoxic - immunology | Transforming Growth Factor beta - immunology | Cytotoxicity, Immunologic - genetics | Tumor Cells, Cultured - immunology | Genetic Vectors - immunology | Antineoplastic Agents - immunology | Hemolysin Proteins | Genetic Vectors - chemical synthesis | Mice, Inbred C57BL | Vaccines, Synthetic - genetics | Interferon-gamma - physiology | Spleen - cytology | Gene Expression Regulation, Viral - immunology | Oncogene Proteins, Viral - biosynthesis | Heat-Shock Proteins - immunology | Cell Line, Transformed - pathology | Cancer Vaccines - immunology | Animals | Bacterial Vaccines - immunology | CD4-Positive T-Lymphocytes - transplantation | Listeria monocytogenes - genetics | Mice | Oncogene Proteins, Viral - immunology | CD8-Positive T-Lymphocytes - immunology | Transforming Growth Factor beta - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
by Punt, Simone and nkers, Emilie C and Welters, M and Goedemans, Renske and Koljenovi, Senada and Bloemena, Elisabeth and Snijders, Peter and Gorter, Arko and Burg, Sjoerd and Baatenburg de Jong, Robert Jan and Jordanova, Ekaterina S
Cancer Immunology, Immunotherapy: other biological response modifications, ISSN 0340-7004, 04/2016, Volume 65, Issue 4, pp. 393 - 403
textabstractPatients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The... 
Head and neck cancer | Th17 cell | Tumor microenvironment | T cell | IL-17 | Treg | SURVIVAL | HEAD | PROGNOSIS | INFILTRATING LYMPHOCYTES | CERVICAL-CANCER | PREVALENCE | IMMUNOLOGY | CLINICAL-RELEVANCE | NECK CANCERS | ONCOLOGY | HUMAN-PAPILLOMAVIRUS STATUS | TH17 CELLS | Forkhead Transcription Factors - immunology | Oropharyngeal Neoplasms - immunology | T-Lymphocytes, Regulatory - metabolism | Humans | Middle Aged | Interleukin-17 - immunology | Male | T-Lymphocytes, Regulatory - immunology | Papillomaviridae - immunology | T-Lymphocytes - metabolism | Th17 Cells - metabolism | Forkhead Transcription Factors - metabolism | Aged, 80 and over | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Granulocytes - metabolism | Papillomavirus Infections - complications | Kaplan-Meier Estimate | CD3 Complex - metabolism | Carcinoma, Squamous Cell - immunology | Oropharyngeal Neoplasms - complications | Tumor Microenvironment - immunology | Interleukin-17 - metabolism | Microscopy, Confocal | Carcinoma, Squamous Cell - complications | CD3 Complex - immunology | Lymphocyte Count | Th17 Cells - immunology | T-Lymphocytes - immunology | Aged | Granulocytes - immunology | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
by Steenwijk, van, P.J.D and Ramwadhdoebe, T.H and Lowik, M.J.G and Minne, van der, C.E and Berends-van der Meer, D and Fathers, L.M and Valentijn, A.R.P.M and Oostendorp, J and Fleuren, G.J and Hellebrekers, B.W.J and Welters, M.J.P and Poelgeest, van, M.I and Melief, C.J.M and Kenter, G.G and Burg, van der, S.H
Cancer Immunology and Immunotherapy, ISSN 0340-7004, 2012, Volume 61, Issue 9, pp. 1485 - 1492
The aim of this study was to investigate the capacity of an HPV16 E6/E7 synthetic overlapping long-peptide vaccine to stimulate the HPV16-specific T-cell... 
Immunology | Medicine & Public Health | Immunotherapy | Vaccination | Oncology | Cancer Research | HSIL | HPV16 | CANCER PATIENTS | IMMUNITY | HEALTHY-SUBJECTS | ANTIGENS | IMMUNOLOGY | CHRONIC VIRAL-INFECTION | LYMPHOCYTE-RESPONSES | T-CELL RESPONSES | ONCOLOGY | NEOPLASIA | THERAPEUTIC VACCINATION | Uterine Cervical Dysplasia - therapy | Papillomavirus Vaccines - therapeutic use | Humans | Papillomavirus E7 Proteins - immunology | Uterine Cervical Neoplasms - immunology | Hypersensitivity, Delayed - immunology | Cervical Intraepithelial Neoplasia - virology | Papillomavirus Infections - therapy | Uterine Cervical Dysplasia - immunology | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Papillomaviridae - immunology | Cervical Intraepithelial Neoplasia - therapy | Repressor Proteins - immunology | Papillomavirus Infections - immunology | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | T-Lymphocytes - immunology | Oncogene Proteins, Viral - immunology | Cervical Intraepithelial Neoplasia - immunology | Uterine Cervical Neoplasms - therapy | Short Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells
by Lenz, Petra and Day, Patricia M and Pang, Yuk-Ying S and Frye, Stephan A and Jensen, Peter N and Lowy, Douglas R and Schiller, John T
The Journal of Immunology, ISSN 0022-1767, 05/2001, Volume 166, Issue 9, pp. 5346 - 5355
The role of viral structural proteins in the initiation of adaptive immune responses is poorly understood. To address this issue, we focused on the effect of... 
EPIDERMAL LANGERHANS CELLS | IMMUNE-RESPONSE | LEISHMANIA-MAJOR | CYTOKINE PRODUCTION | MANNOSE RECEPTOR | VIRUS-LIKE PARTICLES | MAJOR CAPSID PROTEIN | CERVICAL-CANCER | IMMUNOLOGY | HERPES-SIMPLEX VIRUS | T-CELLS | JC Virus - immunology | Dendritic Cells - immunology | Humans | Interphase - immunology | Th1 Cells - immunology | Papillomaviridae - genetics | Th1 Cells - virology | Lymphocyte Activation - immunology | Papillomaviridae - immunology | Cattle | Virus Assembly - genetics | Inflammation Mediators - metabolism | Oncogene Proteins, Viral - genetics | Capsid - metabolism | Dendritic Cells - virology | Dendritic Cells - metabolism | Oncogene Proteins, Viral - metabolism | Virion - immunology | Cytokines - metabolism | Mice, Inbred C57BL | Cells, Cultured | Immunophenotyping | Protein Binding - immunology | BK Virus - immunology | Capsid - immunology | Cell Differentiation - immunology | Animals | Virus Assembly - immunology | Capsid Proteins | Bovine papillomavirus 1 - immunology | Mice | Oncogene Proteins, Viral - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dendritic cells primed with HPV positive cervical tumor lysate are superior to unprimed DCs in migratory capacity and induce a potent Th1 response
by Ramanathan, Priya and Dhandapani, Hemavathi and Jayakumar, Hascitha and Ganeshrajah, Selvaluxmy and Thangarajan, Rajkumar
Human Immunology, ISSN 0198-8859, 2014, Volume 75, Issue 12, pp. 1216 - 1224
Abstract In this study, we assessed the efficacy of tumor lysate primed and unprimed monocyte derived mature dendritic cells (DCs) to trigger an effective... 
Allergy and Immunology | Th1 response | Dendritic cells | IL-12p40 | Cervical cancer | HPV | DISTINCT | CYTOKINE | KAPPA-B | IMMUNOLOGY | IL-12 | MATURATION | INTERLEUKIN-6 | INHIBITION | ADJUVANTS | GENERATION | ANTIGEN | Antigens, CD - immunology | Cell Proliferation | Immunoglobulins - immunology | Dendritic Cells - immunology | Humans | Interleukin-12 Subunit p40 - secretion | Th1 Cells - immunology | Lymphocyte Culture Test, Mixed | Cell Movement - immunology | Lymphocyte Activation - immunology | Female | Membrane Glycoproteins - immunology | B7-2 Antigen - immunology | Chemokine CCL21 - pharmacology | Endocytosis - immunology | Adjuvants, Immunologic | B7-1 Antigen - immunology | Interferon-gamma - secretion | Uterine Cervical Neoplasms - immunology | Cell Movement - drug effects | Chemokine CCL19 - pharmacology | Uterine Cervical Neoplasms - virology | Papillomaviridae | HLA-DR Antigens - immunology | CD8-Positive T-Lymphocytes - immunology | DNA, Viral - genetics | CD40 Antigens - immunology | Papillomavirus infections | Immunotherapy | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
by Nordfors, Cecilia and Grün, Nathalie and Tertipis, Nikolaos and Ährlund-Richter, Andreas and Haeggblom, Linnea and Sivars, Lars and Du, Juan and Nyberg, Tommy and Marklund, Linda and Munck-Wikland, Eva and Näsman, Anders and Ramqvist, Torbjörn and Dalianis, Tina
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 11, pp. 2522 - 2530
Abstract Patients with human papillomavirus (HPV) positive tonsillar and base of tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) have a better... 
Hematology, Oncology and Palliative Medicine | CD8+ TILs | Clinical outcome | Base of tongue cancer | CD4+ TILs | Tonsillar cancer | HPV | CD4 | CD8 | TILs | HEAD | PROGNOSIS | VACCINE | RISK | CERVICAL-CANCER | NECK-CANCER | ONCOLOGY | CD4(+) TILs | OROPHARYNGEAL CANCER | CD8(+) TILs | EPIDEMIC | EXPRESSION | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Tonsillar Neoplasms - immunology | CD4-Positive T-Lymphocytes - immunology | Papillomaviridae - immunology | Squamous Cell Carcinoma of Head and Neck | Tongue Neoplasms - virology | Aged, 80 and over | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Tonsillar Neoplasms - therapy | Tonsillar Neoplasms - pathology | Tongue Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Papillomaviridae - isolation & purification | Carcinoma, Squamous Cell - immunology | Tongue Neoplasms - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - immunology | Pilot Projects | Tonsillar Neoplasms - virology | Aged | Tongue Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Developments in L2-based human papillomavirus (HPV) vaccines
by Schellenbacher, Christina and Roden, Richard B.S and Kirnbauer, Reinhard
Virus Research, ISSN 0168-1702, 03/2017, Volume 231, pp. 166 - 175
Infections with sexually transmitted high-risk Human Papillomavirus (hrHPV), of which there are at least 15 genotypes, are responsible for a tremendous disease... 
HPV infection and disease | Human papillomavirus (HPV) vaccine | Squamous cell cancer (SCC) | Cutaneous and anogenital warts (condylomata) | Minor capsid protein (L2) | Cervical cancer (CxCa) | L1 PROTEIN | CROSS-NEUTRALIZATION | CELL-SURFACE | MINOR CAPSID PROTEIN | INTRAEPITHELIAL NEOPLASIA | HPV-16/18 AS04-ADJUVANTED VACCINE | IN-VITRO | VIROLOGY | VIRUS-LIKE PARTICLES | COMMON NEUTRALIZATION EPITOPE | IMMUNOGENIC DISPLAY | Immunogenicity, Vaccine | Recombinant Fusion Proteins - immunology | Head and Neck Neoplasms - virology | Oncogene Proteins, Viral - chemistry | Papillomaviridae - drug effects | Humans | Vaccination | Cross Protection | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Epitopes - immunology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Capsid Proteins - chemistry | Vaccines, Virus-Like Particle | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Antibodies, Viral - biosynthesis | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaccines, Subunit - immunology | Recombinant Fusion Proteins - chemistry | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Animals | Vaccines, Subunit - biosynthesis | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Epitopes - chemistry | Mice | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Prevention | Vaccines | Viral proteins | Health aspects | Papillomavirus infections | Wildlife conservation | Peptides | Development and progression | Papillomaviruses | Warts | Sexually transmitted diseases | Analysis | Skin | Cervical cancer | Antigenic determinants | Human Papillomavirus (HPV) Vaccine | Cervical Cancer (CxCa) | Minor Capsid Protein (L2) | Squamous Cell Cancer (SCC) | cutaneous and anogenital warts (condylomata)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types
by Zhang, Ting and Liu, Hongyang and Chen, Xue and Wang, Zhirong and Wang, Shuo and Qu, Chunfeng and Zhang, Jingzhi and Xu, Xuemei
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 46, pp. 5531 - 5539
Abstract Numerous types of human papillomaviruses (HPVs) have been identified, and the global burden of diseases associated with HPV infection is remarkable,... 
Allergy and Immunology | Papillomavirus | hFcγRI targeting | Lipoprotein | GLOBAL BURDEN | MEDICINE, RESEARCH & EXPERIMENTAL | PROTECTION | hFc gamma RI targeting | VACCINE | IMMUNOLOGY | MINOR CAPSID PROTEIN | CHALLENGE | RESPONSES | SENSITIVE MEASURE | MONOCLONAL-ANTIBODIES | FUSION PROTEINS | Immunogenicity, Vaccine | Oncogene Proteins, Viral - administration & dosage | Papillomaviridae - chemistry | Oncogene Proteins, Viral - chemistry | Capsid Proteins - administration & dosage | Humans | Cross Protection | Receptors, IgG - immunology | Epitopes - immunology | Antibodies, Neutralizing - immunology | Papillomaviridae - immunology | Animals | Immunoglobulin Fc Fragments - immunology | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Capsid Proteins - chemistry | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - immunology | Vaccines, Virus-Like Particle - immunology | Mice | Mice, Inbred BALB C | Oncogene Proteins, Viral - immunology | Papillomavirus Vaccines - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region
by Kondo, Kazunari and Ishii, Yoshiyuki and Ochi, Hiroyuki and Matsumoto, Tamae and Yoshikawa, Hiroyuki and Kanda, Tadahito
Virology, ISSN 0042-6822, 2006, Volume 358, Issue 2, pp. 266 - 272
Abstract Neutralizing antibody against human papillomavirus (HPV) minor capsid protein L2 can cross-neutralize different HPV genotypes in vitro. To identify... 
Infectious Disease | Minor capsid protein L2 | Neutralization epitope | HPV16 | Antibody Specificity | Oncogene Proteins, Viral - administration & dosage | Human papillomavirus 18 - immunology | Oncogene Proteins, Viral - chemistry | Antigens, Viral - administration & dosage | Peptides - genetics | Molecular Sequence Data | Neutralization Tests | Human papillomavirus 16 - immunology | Vaccines, Synthetic - immunology | Papillomavirus Infections - blood | Epitopes - immunology | Papillomaviridae - immunology | Peptides - chemical synthesis | Injections, Subcutaneous | Capsid Proteins - chemistry | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - administration & dosage | Amino Acid Sequence | Immune Sera - immunology | Rabbits | Immunization | Capsid Proteins - administration & dosage | Peptides - immunology | Cross Reactions | Antigens, Viral - immunology | Animals | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Vaccines, Synthetic - administration & dosage | Proteins | Peptides
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text HPV and systemic lupus erythematosus: a mosaic of potential crossreactions
by Segal, Yahel and Dahan, Shani and Calabrò, Michele and Kanduc, Darja and Shoenfeld, Yehuda
Immunologic Research, ISSN 0257-277X, 04/2017, Volume 65, Issue 2, pp. 564 - 571
Etiology, pathogenesis, and immunology of systemic lupus erythematosus (SLE) form a complex, still undeciphered picture that recently has been further made... 
HERV | Crossreactivity | EBV | SLE | HPV | LOW-SIMILARITY | AUTOANTIGEN | IMMUNOLOGY | TYROSINE-PHOSPHATASE | DEFICIENCY | ENDOGENOUS RETROVIRUSES | FUNCTIONAL VARIANT | MOLECULAR MIMICRY | ASSOCIATION | EXPRESSION | EPSTEIN-BARR-VIRUS | Autoimmunity | Epitope Mapping | Humans | Antigens, CD19 - genetics | Antibodies, Viral - blood | Receptors, Natural Killer Cell - immunology | Ku Autoantigen - genetics | Papillomaviridae - immunology | Peptide Fragments - immunology | Lupus Erythematosus, Systemic - immunology | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Peptide Fragments - genetics | Antigens, CD19 - immunology | Oncogene Proteins, Viral - metabolism | Peptide Fragments - metabolism | Complement C4 - metabolism | Capsid Proteins - metabolism | Lupus Erythematosus, Systemic - virology | Receptors, Natural Killer Cell - metabolism | Ku Autoantigen - immunology | Ku Autoantigen - metabolism | Complement C4 - immunology | Complement C4 - genetics | Cross Reactions | Papillomavirus Vaccines - immunology | Antigens, CD19 - metabolism | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Receptors, Natural Killer Cell - genetics | Proteins | Lupus | Antigens | Killer cells | Systemic lupus erythematosus | Analysis | Transplantation of organs, tissues, etc | Development and progression | Health aspects | Papillomavirus infections | Human papillomavirus | Hypotheses | Immune response | Immunology | Peptides | Autoimmune diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses
by Scherpenisse, Mirte and Schepp, Rutger M and Mollers, Madelief and Meijer, Chris J. L. M and Berbers, Guy A. M and van der Klis, Fiona R. M
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e74797
Objectives: In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral antibody response that will provide insight in... 
IMMUNOGENICITY | ASSAY | EFFICACY | MARKER | SAFETY | MULTIDISCIPLINARY SCIENCES | RISK | HUMAN-PAPILLOMAVIRUS INFECTIONS | PREVALENCE | SEROPREVALENCE | VACCINES | Human papillomavirus 18 - immunology | Species Specificity | Humans | Middle Aged | Vaccination | Child, Preschool | Antibody Affinity - immunology | Infant | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Papillomavirus Infections - blood | Young Adult | Antibodies, Neutralizing - immunology | Papillomaviridae - immunology | Immunoglobulin G - immunology | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Child | Infant, Newborn | Antibody Formation - immunology | Cross Reactions - immunology | Papillomavirus Infections - prevention & control | Adolescent | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Aged | Antigen-antibody reactions | Infection | Medical research | Immunoglobulin G | Medicine, Experimental | Health aspects | Multiplexing | Immunoassay | Laboratories | Antibodies | Homology | Infections | Vaccines | Epidemiology | Medical ethics | Antibody response | Human papillomavirus | Inhibition | Age | Public health | Immune system | Immunoglobulins | Immune response | Cross-reactivity | Immune response (humoral) | Pathology | Infectious diseases | Reactivity | Surveillance | Womens health | Neutralizing | Avidity | Cervical cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights